IndraLab

Statements


| 13

sparser
"This dissolution profiles were compared against the USP acceptance criteria for metoprolol succinate ER tablets ( USP39-NF34, 2015 )."

sparser
"Tablet dissolution was performed using USP dissolution apparatus II as described in the USP monograph of metoprolol succinate ER tablets ( USP39-NF34, 2015 )."

sparser
"The concentrations of metoprolol in the dissolution media were determined per the chromatographic method stated in USP monographs with minor modifications ( USP39-NF34, 2015 )."

sparser
"The drug release studies were performed using USP dissolution apparatus II as established by the USP monograph of metoprolol succinate ER tablets ( USP39-NF34, 2015 )."

sparser
"An extragranular fraction of HPMC K100M was added to achieve the dissolution characteristics that met the USP acceptance criteria for the metoprolol succinate ER tablets ( USP39-NF34, 2015 )."

sparser
"The chromatographic method was used to determine metoprolol concentration following the USP monographs with minor modifications ( USP39-NF34, 2015 )."

sparser
"This dissolution characteristics was compared against the USP acceptance criteria for metoprolol succinate ER tablets ( USP39-NF34, 2015 )."

sparser
"These dissolution profiles met the acceptance criteria enumerated in the USP monograph of metoprolol succinate ER tablets ( USP39-NF34, 2015 )."

sparser
"These dissolution characteristics met the acceptance criteria listed in the USP monograph of metoprolol succinate ER tablets ( USP39-NF34, 2015 )."

sparser
"The quantitation of Oxytocin was performed according to the USP monograph of Oxytocin injections with some minor modification ( USP39-NF34, 2015 )."

sparser
"Dissolution testing was performed for six random chosen tablets per batch using USP dissolution apparatus II as described in the USP monograph of metoprolol succinate ER tablets ( USP39-NF34, 2015 )."

sparser
"Concentrations of metoprolol in dissolution media were determined per the chromatographic method stated in USP monographs with minor modifications ( USP39-NF34, 2015 )."

sparser
"An extra-granular fraction of HPMC K100M was added to ensure that tablets meet the acceptance criteria for drug dissolution listed in the USP monograph of metoprolol succinate ER tablets ( USP39-NF34,[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"